← back to search

Vincenzo Cerundolo

John Radcliffe Hospital · GB
Area of research
Immunology · Oncology
Research interest
Research interests include Immune Cell Function and Interaction, Immunotherapy and Immune Responses, T-cell and B-cell Immunology, and CAR-T cell therapy research.
h-index
103
citations
38,269
works
480
NIH funding
primary concept
Biology
email

Recent publications

Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells
Nature Communications 2024cited by 26position: lastdoi
Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells
Nature Communications 2024cited by 3position: lastdoi
Movie S4 from Self-Maintaining CD103<sup>+</sup> Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses
2023cited by 0position: contributordoi
Movie S3 from Self-Maintaining CD103<sup>+</sup> Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses
2023cited by 0position: contributordoi
Supplemental File For Publication from Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8<sup>+</sup> Tumor-Infiltrating T Lymphocyte Responses
2023cited by 0position: contributordoi
Movie S1 from Self-Maintaining CD103<sup>+</sup> Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses
2023cited by 0position: contributordoi
Movie S1 from Self-Maintaining CD103<sup>+</sup> Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses
2023cited by 0position: contributordoi
Data from Self-Maintaining CD103<sup>+</sup> Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses
2023cited by 0position: contributordoi
Supplementary Movie Titles and Legends from Self-Maintaining CD103<sup>+</sup> Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses
2023cited by 0position: contributordoi
Data from Self-Maintaining CD103<sup>+</sup> Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses
2023cited by 0position: contributordoi
Movie S2 from Self-Maintaining CD103<sup>+</sup> Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses
2023cited by 0position: contributordoi
Data from Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8<sup>+</sup> Tumor-Infiltrating T Lymphocyte Responses
2023cited by 0position: contributordoi
Data from Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells
2023cited by 0position: contributordoi
Supplementary File S1 from Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells
2023cited by 0position: contributordoi
Supplementary Figures and Tables from Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells
2023cited by 0position: contributordoi
Supplementary Fig S1-7, Sup Table 1 from Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8<sup>+</sup> Tumor-Infiltrating T Lymphocyte Responses
2023cited by 0position: contributordoi
Supplementary Fig S1-7, Sup Table 1 from Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8<sup>+</sup> Tumor-Infiltrating T Lymphocyte Responses
2023cited by 0position: contributordoi
Data from Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8<sup>+</sup> Tumor-Infiltrating T Lymphocyte Responses
2023cited by 0position: contributordoi
Supplementary Figures 1-7 and Supplementary Tables 1-2 from Self-Maintaining CD103<sup>+</sup> Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses
2023cited by 0position: contributordoi
Supplementary File S1 from Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells
2023cited by 0position: contributordoi
Data from Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells
2023cited by 0position: contributordoi
Supplemental File For Publication from Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8<sup>+</sup> Tumor-Infiltrating T Lymphocyte Responses
2023cited by 0position: contributordoi
Supplementary Figures 1-7 and Supplementary Tables 1-2 from Self-Maintaining CD103<sup>+</sup> Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses
2023cited by 0position: contributordoi
Supplementary Figures and Tables from Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells
2023cited by 0position: contributordoi
Movie S4 from Self-Maintaining CD103<sup>+</sup> Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses
2023cited by 0position: contributordoi
Movie S3 from Self-Maintaining CD103<sup>+</sup> Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses
2023cited by 0position: contributordoi
Supplementary Movie Titles and Legends from Self-Maintaining CD103<sup>+</sup> Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses
2023cited by 0position: contributordoi
Movie S2 from Self-Maintaining CD103<sup>+</sup> Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses
2023cited by 0position: contributordoi
The P5-type ATPase ATP13A1 modulates major histocompatibility complex I-related protein 1 (MR1)-mediated antigen presentation.
2022cited by 11position: contributordoi
Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation
Cell Reports 2021cited by 57position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

· 34 papers (2019–2023)Clare Verrill · Health Data Research UK23 papers (2019–2023)Christopher P. Conlon · University of Oxford22 papers (2019–2023) · 22 papers (2019–2023)Megat Abd Hamid · Australian National University22 papers (2019–2023)Nasullah Khalid Alham · John Radcliffe Hospital15 papers (2020–2023)Uzi Gileadi · MRC Human Immunology Unit10 papers (2019–2023) · 8 papers (2019–2023)Vivian Wing Chong Lau · McMaster University7 papers (2020–2023)Zhiyuan Hu · Southeast University7 papers (2020–2023)José Antonio Enriquez · Centro de Investigaciones Cardiovasculares7 papers (2020–2023) · 7 papers (2019–2023)Mara Artibani · Medical Research Council7 papers (2020–2023)Jan Rehwinkel · Indian Institute of Science Education and Research Pune7 papers (2020–2023)Mariolina Salio · University of Oxford6 papers (2019–2022)Tao Dong · Chinese Academy of Medical Sciences & Peking Union Medical College4 papers (2016–2020) · 3 papers (2012–2021)Andrew J. Pollard · Capgemini (United Kingdom)3 papers (2016–2019)Corinna A. Kulicke · Oregon Health & Science University3 papers (2019–2022)Gurdyal S. Besra · University of Birmingham3 papers (2019–2022)